Health Canada inspection
Zhejiang Haizhou Pharmaceutical Co., Ltd.: Health Canada inspection of Sep 16, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Zhejiang Haizhou Pharmaceutical Co., Ltd. |
|---|---|
| City | Linhai |
| Province | Zhejiang |
| Country | China |
| Program | GMP |
| Start date | Sep 15, 2022 |
| End date | Sep 16, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.